6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
11m ago	FatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m ago	Angle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
37m ago	Century Complete Announces New Homes Coming Soon to Fleming Island, FL
38m ago	Sprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
38m ago	Tambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

About

Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) — investor relations, events, news, and company updates on 6ix.

Latest News

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer

Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Financials

Revenue

$7.7 M

Market Cap

$3.9 B

EPS

-4.95

Community Chat

Ask AI